These findings are consistent with previous studies showing that inhibition of GPX4 expression by siRNA in HCC cells increased the formation of Vascular endothelial growth factor (VEGF) and IL-8 cytokines [162], which are both clinically relevant adverse prognostic factors in HCC patients [162,163]. The gene discussed is VEGFA; the disease is hepatocellular carcinoma.